Skip to main content
Log in

Dual knockdown of p65 and p50 subunits of NF-kappaB by siRNA inhibits the induction of inflammatory cytokines and significantly enhance apoptosis in human primary synoviocytes treated with tumor necrosis factor-alpha

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

In order to develop an anti-NF-κB siRNA as a novel class of anti-inflammatory drug, we have isolated a highly efficient siRNA targeting the p65 (RelA) subunit of NF-κB, hereafter named REL1096. To determine whether down-regulation of p65 by REL1096 can block the induction of inflammatory cytokines after treatment with tumor necrosis factor-alpha (TNF-α), human primary fibroblast-like synoviocytes were isolated from patients with rheumatoid arthritis. When treated with REL1096, the TNF-mediated induction of downstream target genes such as inflammatory cytokines, chemokines, and anti-apoptosis genes was drastically inhibited. To enhance the inhibitory effect of REL1096, cells were treated with siRNA targeting the p50 subunit of NF-κB together with REL1096. In addition to effective downregulation of inflammatory cytokines, knockdown of both p65 and p50 resulted in much more extensive apoptosis when compared to cells treated with either REL1096 or p50-siRNA alone. Thus, our results provide evidence for the potential use of siRNA targeting NF-κB as an effective means to treat rheumatoid arthritis. In addition to effective amelioration of synovial inflammation by downregulation of inflammatory cytokines, increased apoptosis by dual knockdown of p65 and p50 may prove advantageous in preventing invasiveness and destructiveness of hyperplastic synoviocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

TNF-α:

Tumor necrosis factor-alpha

RA:

Rheumatoid arthritis

IκB:

Inhibitor κB

IKK:

IκB kinase complex

CIA:

Collagen-induced arthritis

FLSs:

Fibroblast-like synoviocytes

References

  1. Firestein GS (1996) Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 39:1781–1790

    Article  PubMed  CAS  Google Scholar 

  2. Collart MA, Baeuerle P, Vassalli P (1990) Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 10:1498–1506

    PubMed  CAS  Google Scholar 

  3. Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10:2327–2334

    PubMed  CAS  Google Scholar 

  4. Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225–260

    Article  PubMed  CAS  Google Scholar 

  5. Asahara H, Asanuma M, Ogawa N et al (1995) High DNA-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis. Biochem Mol Biol Int 37:827–832

    PubMed  CAS  Google Scholar 

  6. Marok R, Winyard PG, Coumbe A et al (1996) Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 39:583–591

    Article  PubMed  CAS  Google Scholar 

  7. Auphan N, DiDonato JA, Rosette C et al (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286–290

    Article  PubMed  CAS  Google Scholar 

  8. Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396:77–80

    Article  PubMed  CAS  Google Scholar 

  9. Jeon KI, Jeong JY, Jue DM (2000) Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase. J Immunol 164:5981–5989

    PubMed  CAS  Google Scholar 

  10. Wahl C, Liptay S, Adler G et al (1998) Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 101:1163–1174

    Article  PubMed  CAS  Google Scholar 

  11. Majumdar S, Aggarwal BB (2001) Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation. J Immunol 167:2911–2920

    PubMed  CAS  Google Scholar 

  12. Tomita T, Takeuchi E, Tomita N et al (1999) Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum 42:2532–2542

    Article  PubMed  CAS  Google Scholar 

  13. Tak PP, Gerlag DM, Aupperle KR et al (2001) Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum 44:1897–1907

    Article  PubMed  CAS  Google Scholar 

  14. Choung S, Kim YJ, Kim S et al (2006) Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem Biophys Res Commun 342:919–927

    Article  PubMed  CAS  Google Scholar 

  15. Bai S, Liu H, Chen KH et al (2004) NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis. Arthritis Rheum 50:3844–3855

    Article  PubMed  CAS  Google Scholar 

  16. Bernal-Mizrachi L, Lovly CM, Ratner L (2006) The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. Proc Natl Acad Sci U S A 103:9220–9225

    Article  PubMed  CAS  Google Scholar 

  17. Karin M, Cao Y, Greten FR et al (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301–310

    Article  PubMed  CAS  Google Scholar 

  18. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6:203–208

    Article  PubMed  CAS  Google Scholar 

  19. Beg AA, Baltimore D (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274:782–784

    Article  PubMed  CAS  Google Scholar 

  20. Palao G, Santiago B, Galindo M et al (2004) Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis Rheum 50:2803–2810

    Article  PubMed  CAS  Google Scholar 

  21. Liu CY, Takemasa A, Liles WC et al (2003) Broad-spectrum caspase inhibition paradoxically augments cell death in TNF-alpha-stimulated neutrophils. Blood 101:295–304

    Article  PubMed  CAS  Google Scholar 

  22. Schiffelers RM, Xu J, Storm G et al (2005) Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis Rheum 52:1314–1318

    Article  PubMed  CAS  Google Scholar 

  23. Inoue A, Takahashi KA, Mazda O et al (2005) Electro-transfer of small interfering RNA ameliorated arthritis in rats. Biochem Biophys Res Commun 336:903–908

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the International Joint R&D Program (10014823) from the Ministry of Commerce, Industry, and Energy in Korea to Y-C Choi.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Chang-Whan Han or Young-Chul Choi.

Additional information

Ui Jin Lee and So-Rim Choung contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, U.J., Choung, SR., Prakash, K.V.B. et al. Dual knockdown of p65 and p50 subunits of NF-kappaB by siRNA inhibits the induction of inflammatory cytokines and significantly enhance apoptosis in human primary synoviocytes treated with tumor necrosis factor-alpha. Mol Biol Rep 35, 291–298 (2008). https://doi.org/10.1007/s11033-007-9084-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-007-9084-4

Keywords

Navigation